Current investments

Receive information about upcoming investment opportunities

Sign up below to get information about upcoming investment opportunities and investor lunch meetings with the companies’ management.

Completed investments

Sciety_invests_in_Elypta

Elypta

Elypta has developed a new method for early cancer diagnosis. Liquid Biopsy is a rapidly growing field that is expected to be of great importance for cancer diagnosis.

Read more

Athera Biotechnologies

The company is in Phase II with a pharmaceutical candidate for a life-threatening illness for which there are currently no sufficient therapies.

Read more
Sciety_Predicare-RETTS

Predicare

Predicare is the company behind the system RETTS©, used by 95% of Sweden’s hospitals and ambulances. RETTS© daily helps healthcare professionals to make the right decisions in emergency situations.

Read more

Single Technologies

The company has developed a DNA sequencing solution with significantly improved performance compared with current alternatives. The market is growing rapidly in terms of both research and clinical applications.

Read more

Exits

Sciety_Cartana_NeuroKits

Cartana

Cartana’s patent-applied research tool revolutionizes the possibility of analyzing tissue samples, providing pharmaceutical companies with important information in their quest for new treatments.

Read more

Inhalation Sciences

Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.

Read more

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Read more

Raytelligence

Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company is aimed at elderly care in the home.

Read more